These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 38397377)

  • 21. The effect of various zinc binding groups on inhibition of histone deacetylases 1-11.
    Madsen AS; Kristensen HM; Lanz G; Olsen CA
    ChemMedChem; 2014 Mar; 9(3):614-26. PubMed ID: 24375963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
    Li Y; Seto E
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of histone deacetylase 3 by metal cations and 10-hydroxy-2E-decenoic acid: Possible epigenetic mechanisms of queen-worker bee differentiation.
    Polsinelli GA; Yu HD
    PLoS One; 2018; 13(12):e0204538. PubMed ID: 30532259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of HDACs in normal and malignant hematopoiesis.
    Wang P; Wang Z; Liu J
    Mol Cancer; 2020 Jan; 19(1):5. PubMed ID: 31910827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-sirtuin histone deacetylases in the control of cardiac aging.
    Ferguson BS; McKinsey TA
    J Mol Cell Cardiol; 2015 Jun; 83():14-20. PubMed ID: 25791169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension.
    Kee HJ; Kim I; Jeong MH
    Biochem Pharmacol; 2022 Aug; 202():115111. PubMed ID: 35640713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Zinc-dependent HDACs: Non-histone Substrates and Catalytic Deacylation Beyond Deacetylation.
    Zheng W
    Mini Rev Med Chem; 2022; 22(19):2478-2485. PubMed ID: 35362374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting histone deacetylases for heart diseases.
    Jin G; Wang K; Zhao Y; Yuan S; He Z; Zhang J
    Bioorg Chem; 2023 Sep; 138():106601. PubMed ID: 37224740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone deacetylases as targets in autoimmune and autoinflammatory diseases.
    Hamminger P; Rica R; Ellmeier W
    Adv Immunol; 2020; 147():1-59. PubMed ID: 32981634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.
    Kee HJ; Kook H
    J Biomed Biotechnol; 2011; 2011():928326. PubMed ID: 21151616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents.
    Wahi A; Jain P; Sinhari A; Jadhav HR
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):675-702. PubMed ID: 37615708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics.
    Hadnagy A; Beaulieu R; Balicki D
    Mol Cancer Ther; 2008 Apr; 7(4):740-8. PubMed ID: 18413789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small molecule inhibitors of zinc-dependent histone deacetylases.
    Wagner FF; Weїwer M; Lewis MC; Holson EB
    Neurotherapeutics; 2013 Oct; 10(4):589-604. PubMed ID: 24101253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic control of tissue-type plasminogen activator synthesis in human endothelial cells.
    Dunoyer-Geindre S; Kruithof EK
    Cardiovasc Res; 2011 Jun; 90(3):457-63. PubMed ID: 21282301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the epigenome: Screening bioactive compounds that regulate histone deacetylase activity.
    Godoy LD; Lucas JE; Bender AJ; Romanick SS; Ferguson BS
    Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27981795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis.
    Xu L; Yan X; Wang J; Zhao Y; Liu Q; Fu J; Shi X; Su J
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases.
    Frühauf A; Meyer-Almes FJ
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDACs regulate the differentiation of endothelial cells from human iPSCs.
    Li T; Wu H; Wang P; Kim AM; Jia J; Nolta JA; Zhou P
    Cell Biochem Funct; 2022 Aug; 40(6):589-599. PubMed ID: 35789099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.
    Konsoula Z; Barile FA
    J Pharmacol Toxicol Methods; 2012; 66(3):215-20. PubMed ID: 22902970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone deacetylases in modulating cardiac disease and their clinical translational and therapeutic implications.
    Wang Z; Zhao YT; Zhao TC
    Exp Biol Med (Maywood); 2021 Jan; 246(2):213-225. PubMed ID: 32727215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.